N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment DOI Creative Commons
Xiaoyue Li,

Lin Peng,

Xuelian Yang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 20, 2024

N6-methyladenosine is one of the most common and reversible post-transcriptional modifications in eukaryotes, it involved alternative splicing RNA transcription, degradation, translation. It well known that cancer cells acquire energy through metabolic reprogramming to exhibit various biological behaviors. Moreover, numerous studies have demonstrated m6A induces by regulating expression core genes or activating signaling pathways. Meanwhile, related regulators are key targets regulation immune effects. We further summarize how contribute tumor metabolism, these events affect microenvironment, with a specific focus on different cell types. Finally, we applications this field immunotherapy. review potential role microenvironment its regulatory mechanism, aim providing new for

Language: Английский

Advancements in research on lactate dehydrogenase A in urinary system tumors DOI Creative Commons

Zhiyuan Zhuo,

Yu Wang, Yifan Xu

et al.

BMC Urology, Journal Year: 2024, Volume and Issue: 24(1)

Published: Aug. 30, 2024

Language: Английский

Citations

1

The role of RNA modification in urological cancers: mechanisms and clinical potential DOI Creative Commons
Xuming Zhou,

Hezhen Zhu,

Cong Luo

et al.

Discover Oncology, Journal Year: 2023, Volume and Issue: 14(1)

Published: Dec. 20, 2023

RNA modification is a post-transcriptional level of regulation that widely distributed in all types RNAs, including mRNA, tRNA, rRNA, miRNA, and lncRNA, where N6-methyladenine (m6A) the most abundant mRNA methylation modification. Significant evidence has depicted m6A modifications are closely related to human diseases, especially cancer, play pivotal roles transcription, splicing, stabilization, translation processes. The common urological cancers include prostate, bladder, kidney, testicular cancers, accounting for certain proportion with an ever-increasing incidence mortality. recurrence, systemic metastasis, poor prognosis, drug resistance urologic tumors have prompted identification new therapeutic targets mechanisms. Research on may provide solutions current puzzles. In this review, we comprehensive overview key played by modifications, as well recent research advances diagnostics molecularly targeted therapies.

Language: Английский

Citations

3

N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment DOI Creative Commons
Xiaoyue Li,

Lin Peng,

Xuelian Yang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 20, 2024

N6-methyladenosine is one of the most common and reversible post-transcriptional modifications in eukaryotes, it involved alternative splicing RNA transcription, degradation, translation. It well known that cancer cells acquire energy through metabolic reprogramming to exhibit various biological behaviors. Moreover, numerous studies have demonstrated m6A induces by regulating expression core genes or activating signaling pathways. Meanwhile, related regulators are key targets regulation immune effects. We further summarize how contribute tumor metabolism, these events affect microenvironment, with a specific focus on different cell types. Finally, we applications this field immunotherapy. review potential role microenvironment its regulatory mechanism, aim providing new for

Language: Английский

Citations

0